EGD Masterclass: EoE, Strictures, and Pre-malignant Gastric Conditions (Virtual Only) | January 2023-H. Pylori, Atrophic Gastritis, and Gastric Intestinal Metaplasia

H. Pylori, Atrophic Gastritis, and Gastric Intestinal Metaplasia

Video Transcription

Video Summary

In this video, Dr. Madhav outlines the importance of H. pylori infection, atrophic gastritis, and gastric intestinal metaplasia (GIM) in relation to the risk of gastric cancer. He emphasizes the prevalence of H. pylori, particularly in certain populations, and highlights the stepwise progression from infection to chronic inflammation, atrophic gastritis, and ultimately GIM and gastric cancer. Dr. Madhav stresses the need for proper sampling and detection of H. pylori, as well as the importance of eradication therapy to reduce the risk of cancer. He discusses the endoscopic identification of chronic atrophic gastritis and GIM, as well as the increased risk of neuroendocrine tumors in patients with autoimmune atrophic gastritis. Dr. Madhav explains the updated Sidney classification for endoscopic staging and the American Gastroenterology Association guidelines for management and surveillance of patients with chronic atrophic gastritis and GIM. He concludes by emphasizing the importance of individualized assessment and shared decision-making in determining the need for endoscopic surveillance.

Keywords

H. pylori infection

atrophic gastritis

gastric intestinal metaplasia

gastric cancer

eradication therapy